Abstract: Calcium ions are required for proper function of a wide spectrum of proteins within cells. X-ray crystallography of human glutamate carboxypeptidase II (GCPII) revealed the presence of a Ca 2+ -binding site, but its importance for the structure and function of this metallopeptidase has not been elucidated to date. Here, we prepared a panel of mutants targeting residues that form the Ca 2+ coordination sphere of GCPII and analyzed their structural and enzymatic properties using an array of complementary biophysical and biochemical approaches. Our data unequivocally show that even a slight disruption of the Ca 2+ -binding site destabilizes the three-dimensional fold of GCPII and is associated with impaired secretion, a high propensity to form nonphysiological oligomers, and an inability to bind active site-targeted ligands. Additionally, the Ca 2+ -binding site is critical for maintenance of the native homodimeric quaternary arrangement of GCPII, which is indispensable for its enzymatic activity. Overall, our results offer a clear picture of the importance of Ca 2+ for the structural integrity and hydrolytic activity of human GCPII and by extension homologous members of the M28 zinc-dependent metallopeptidase family.
Introduction
Metal ions are indispensable for the proper function of more than one-third of proteins in the proteome. They are required for efficient protein folding and maintenance of three-dimensional structures, play regulatory roles in biochemical processes within the cell, and are directly involved in enzymatic mechanisms. Aside from sodium and potassium, which typically bind proteins non-specifically and with low affinity, the most biologically important metals include iron, calcium, magnesium, zinc, copper, and manganese. [1] [2] [3] [4] [5] Calcium ions are involved in control of cellular processes ranging from fertilization to programmed cell death, and Ca 2+ plays a key role in gene expression, muscle contraction, and diverse metabolic pathways. (The biological functions of calcium have been reviewed in detail elsewhere.) 6 Ca 2+ homeostasis is tightly regulated, and Ca 2+ release triggers numerous cellular processes. Typically, released Ca 2+ binds to proteins and induces conformational changes. These changes can, for example, regulate enzymatic activity, open or close ion channels, and even drive folding of secreted protein domains on the outer side of the plasma membrane. 7 In addition, Ca 2+ plays a structural, rather than functional, role in many proteins. Human glutamate carboxypeptidase II (GCPII) (EC 3.4.17.21) is a transmembrane zinc-dependent metallopeptidase expressed in various tissues including the central nervous system, 8 small intestine, 9 kidneys, salivary glands, prostate tumor cells, 10 and the neovasculature of most solid tumors. 11, 12 Under physiological conditions, it functions as a homodimer anchored to the plasma membrane via its N-terminal α-helix and plays important roles in absorption of dietary folates in the small intestine (where GCPII is known as folate hydrolase) and regulation of neurotransmission in the central nervous system (where it is known as N-acetylated-alpha-linked acidic dipeptidase, or NAALADase). GCPII has been implicated in several neuropathologies associated with dysregulated glutamatergic signaling, and GCPII-specific inhibitors have been evaluated for the treatment of several neurological disorders, including neuropathic and inflammatory pain, ischemic brain injury, amyotrophic lateral sclerosis, Alzheimer's disease, and Parkinson's disease (reviewed in Ref. 13 ). Additionally, increased levels of GCPII on the surface of prostate carcinoma cells and tumor neovasculature make the protein a suitable biomarker for imaging and therapy of prostate cancer and solid tumors. Given the biomedical potential of GCPII, its structural and enzymatic properties have been studied extensively for more than two decades. GCPII has been assigned to the peptidase family M28, which contains cocatalytic zinc metallopeptidases. X-ray structures of GCPII confirmed the presence of two zinc ions in the active site and helped to decipher their critical role in the catalytic mechanism of the enzyme.
14 Surprisingly, crystallographic data also revealed two additional ions within the GCPII structure: (i) a chloride anion positioned near the active site that is important for the structural integrity of the S1 pocket and (ii) a calcium ion of unknown function [ Fig. 1(A,B) ]. The Ca 2+ ion is coordinated with typical pentagonal bipyramidal geometry 15 by six oxygen atoms from four amino acid residues and a water molecule. The coordination sphere comprises Glu433 (Oε1-2.4 Å, Oε2-2.4 Å) and Glu436 (Oε2-2.3 Å), which belong to the protease domain, and Tyr272 (O -2.3 Å) and Thr269 (O -2.4 Å, Oγ1-2.5 Å) of the apical domain [ Fig. 1(C) ]. Given that Ca 2+ is located~20 Å from the active site, it is unlikely that the ion directly affects the enzymatic activity of GCPII or the architecture of the active site. 16 We hypothesized that the insertion of the Ca 2+ site between the two GCPII structural domains stabilizes the overall fold of the protein. 16 Furthermore, the proximity of the calcium-binding site to the monomer interface suggests that it may be implicated in GCPII dimerization, which is critical for the enzyme's carboxypeptidase activity. 17 This study thus aimed to elucidate the role of the calcium ion in determining the structural and enzymatic properties of human GCPII, using an array of complementary biophysical and biochemical approaches. only through its main chain carbonyl oxygen. Plasmids encoding the desired GCPII variants with an N-terminal BiP secretion signal and SLIN affinity purification tag were prepared by site-directed mutagenesis.
Results

GCPII
All GCPII variants were expressed as secreted proteins using Schneider's S2 cells and purified by a combination of Streptactin affinity chromatography and size-exclusion chromatography (SEC) (Fig. 2) . 18 We observed two major differences during expression and purification of GCPII mutants compared with wild-type GCPII (wtGCPII). First, following the Streptactin affinity step, yields of mutated GCPII variants ranged from 0.2 to 1.3 mg from 1 L of conditioned media,~10-to 50-fold lower than the typical yield of 10 mg/L for wtGCPII. Second, while wtGCPII elutes as a single monodisperse peak during the SEC step, elution profiles for all the mutants indicated two discrete protein populations (Fig. 2) . The high molecular weight form elutes as a broad multipeak, with an estimated size ranging from 300 kDa to larger than 1 MDa, corresponding to GCPII aggregates and multimers. The lower molecular weight monodisperse peak matches that of wtGCPII. The amount of total protein in the two SEC populations varied greatly between individual mutants and even between different batches of the same construct. Typically, the monodisperse form accounted for 10-50% of the total protein yield. Collectively, these data suggest that mutated GCPII variants have a higher propensity to misfold and/or lose their native structure. Clearly, a significant portion of the nascent protein is not folded properly and therefore is likely retained and degraded within the cell, resulting in impaired secretion into the media. For the fraction successfully secreted, the mutated variants have a greater tendency to form aggregates and higher order oligomers. These attributes were most prominent in the case of the poorly expressed E433A/E436A double mutant. Along with the E436A variant, the double mutant was excluded from subsequent biochemical and biophysical experiments.
Mutations in the GCPII calcium-binding site destabilize tertiary and quaternary structure Differences in the behavior of GCPII variants during expression and purification prompted us to analyze their structural characteristics in more detail. Using circular dichroism (CD) spectroscopy, we first compared the secondary structural elements (α-helices and β-sheets) of wtGCPII and the individual GCPII variants (Fig. 3 and Supporting Information Figure S3 ). The wild-type enzyme exhibited a CD curve typical for a globular and folded protein, with mixed α-helical and β-stranded secondary structure. Spectra of all GCPII variants from both monodisperse and multimeric SEC fractions were similar to that of wtGCPII, indicating that most of the secondary structure elements are retained. Deconvolution of the spectra and comparison of estimated secondary structure composition revealed only minor differences between the variants.
While mutations in the Ca 2+ coordination sphere did not profoundly affect the content of secondary structural elements, they destabilized the overall three-dimensional fold. In the absence of crystal structures of the GCPII variants, we used Figure 3 . Secondary, tertiary, and quaternary structure analysis of GCPII variants. The T269S variant retains some biochemical and structural characteristics of wild-type GCPII; T269A serves as a representative of the remaining variants. Preparative SEC: While a single monodisperse peak is observed for wtGCPII (blue), both oligomeric/aggregated (light green, orange), and monodisperse (dark green, red) fractions are seen during preparative SEC, pointing towards alterations in the tertiary/quaternary structure of mutants. CD: CD curves reveal slight perturbations in the secondary structural elements in isolated oligomeric fractions (light colors) compared to monodisperse peaks (dark green, red). nanoDSF: The temperature-induced unfolding step (as determined by nanoDSF) is much less prominent for aggregated/oligomeric fractions, suggesting aberrations in the three-dimensional structures of these species. Analytical SEC: Monodisperse fractions from preparative SEC were re-analyzed using analytical SEC to determine the apparent molecular weights of individual variants (embedded table) . While wtGCPII forms obligatory dimers, the mutants are fully monomeric with the exception of the T269S variant, which exists in monomer/dimer equilibrium.
nanodifferential scanning fluorimetry (nanoDSF) to indirectly infer their three-dimensional folds. Both wtGCPII and the T269S variant from the monodisperse SEC fraction had calculated melting temperatures of 70 C. Analysis of the denaturation curves for the remaining mutants revealed a substantial decrease in melting temperature to~44-47 C. Compared to the monodisperse SEC fractions, the oligomeric fractions either did not show a transition between native and denatured protein or the change in tryptophan fluorescence ratio was much less pronounced (see Fig. 3 for comparison of wtGCPII with T269A and T269S). Our observations suggest that the oligomeric fractions of most variants are devoid of species with a proper three-dimensional fold, while the oligomeric fraction of the T269S variant includes a small proportion of species with the native-like fold. Thus, disruption of the calcium coordination sphere likely leads to substantial destabilization, or even total collapse, of the overall three-dimensional fold of GCPII.
This tertiary destabilization in turn led to disruption of the quaternary arrangement (i.e., homodimerization) of all the GCPII mutants (Fig. 3, analytical SEC) . For the wild-type enzyme, the molecular weight of 165 kDa determined by analytical SEC corresponds to the physiologically relevant homodimer (the mass spectrometry molecular weight of one monomer is 92 kDa). Interestingly, a monomer-dimer equilibrium was observed for the T269S mutant, suggesting that the Ca 2+ -binding site of this variant might in part retain its native fold. All remaining mutants migrated at elution volumes corresponding to molecular weights of 86-95 kDa, indicating monomeric species.
Calcium-binding site mutations disrupt the active site architecture and compromise GCPII activity
We next compared the NAAG-hydrolyzing activity of the purified GCPII variants present in both the monodisperse and multimeric SEC fractions (Fig. 4) .
All GCPII variants present in multimeric/oligomeric fractions were enzymatically inactive. Similarly, the hydrolytic activities of the majority of GCPII mutants from monodisperse fractions were below the detection limit of our assay, with the exception of the T269S mutant. The enzymatic activity of the T269S mutant was~10% of wtGCPII activity. Kinetic analysis revealed that this decrease in NAAG-hydrolyzing activity compared to the wild-type enzyme is linked to the 10-fold slower reaction rate of the T269S mutant; there was virtually no difference in the Michaelis constant for NAAG [ Fig. 4(B) ].
Combined with the quaternary structure analysis, these data indicate that only variants capable of dimerization (i.e., the wild-type and T269S enzymes) are enzymatically competent. Mutations of the Ca 2+ -binding ligands lead to disruption of the dimerization interface, and the ensuing monomeric species retain most of the secondary structural elements but are enzymatically inactive. The loss of enzymatic activity of the GCPII mutants could in principle result from either of two scenarios. Either the substrate can still bind to the active site but cannot be efficiently hydrolyzed or the architecture of the active site is disrupted to preclude substrate binding. To distinguish between these two possibilities, we evaluated GCPII interactions with active site-targeted ligands using two complementary approaches-fluorescence polarization (FP) assay and nanoDSF.
For the FP assay, we used TMR-X-Lys-urea-Glu, a urea-based inhibitor covalently linked to the Bodipy TMR-X-Lys-urea-Glu fluorophore. As reported previously, binding of TMR-X-Lys-urea-Glu to the GCPII active site in a substrate-like manner is associated with a marked increase in FP readout. 19 Our data
show that only the wild-type and T269S variants are capable of TMR-X-Lys-urea-Glu binding, while the architecture of the substrate-binding pockets of the remaining mutants is substantially disrupted, precluding TMR-X-Lys-urea-Glu binding [ Fig. 5(A) ]. Titrating increasing amounts of wild-type and T269S GCPII against a constant concentration of the TMR-X-Lys-urea-Glu probe revealed that an~4-fold higher concentration of T269S GCPII is needed to reach the maximum FP signal [ Fig. 5(B) ]. These results corroborate data from the enzymatic assay and suggest that only a fraction (likely dimeric) of the T269S variant is capable of substrate/inhibitor binding. As a complementary approach, we used nanoDSF to elucidate the thermal stability of the GCPII variants and their capacity to bind CTT54, a transition-state mimetic. 20 When GCPII variants were preincubated with CTT54, we observed substantial increases in the thermal stability of both the wild-type and T269S variants (16 C and 14 C, respectively). The melting temperatures of the remaining GCPII mutants remained unchanged [ Fig. 5(C,D) ]. These data underscore our observations that only the wild-type and T269S variants retain an active site architecture capable of binding and processing ligands and substrates.
Discussion
The M28 family in the MEROPS database contains both co-catalytic zinc-dependent aminopeptidases and carboxypeptidases, with Streptomyces griseus aminopeptidase (SGAP) being one of the most extensively studied members of the family. [21] [22] [23] [24] [25] [26] The M28B subfamily, to which human GCPII belongs, includes peptidases homologous to GCPII as well as the transferrin receptor (TfR), a protein devoid of enzymatic activity. X-ray structures for three GCPII homologs from the M28B subfamily are available in the Protein Data Bank: glutamate carboxypeptidase III (GCP3), 27 N-acetylated alpha-linked acidic dipeptidase-like protein (NAALADaseL), 28 and TfR. 29, 30 The partial sequence and structural alignments of these homologs and SGAP 31 are shown in Figure 6 .
The overall three-dimensional fold, domain organization, and homodimer interface are highly conserved among the M28B subfamily members, despite their differences in enzymatic properties. Most importantly, a calcium ion is present in all four M28B proteins, with a virtually identical coordination sphere, indicating phylogenetic conservation of this feature. Given that TfR lacks enzymatic activity, it is likely that Ca 2+ plays a solely structural role in this protein. SGAP differs from the M28B family members as it is much smaller and comprises only the catalytic, not the apical, domain. Not surprisingly, the Ca 2+ ion is missing from the SGAP structure, as it is not required to maintain the three-dimensional fold of the enzyme. Our data reveal the importance of the Ca 2+ ion for the folding, stability and activity of human GCPII and by extension likely the entire M28B subfamily. To the best of our knowledge, the only other work addressing the importance of Ca 2+ for the structure and function of a M28B family member is a mutagenesis study of TfR. 32 The authors reported that double mutation of glutamates 465 and 468 (corresponding to E433 and E436 in human GCPII) to alanines lowered the expression yield of TfR more than 40-fold compared to the wild-type protein. Following SEC, mutated TfR was present only in aggregated or oligomeric forms, preventing further experimentation. These previous findings correlate well with the results presented here, including the lower expression levels of GCPII mutants and their propensity to form higher molecular weight oligomers and aggregates. The T269S variant is the only GCPII mutant that retained some wtGCPII-like properties, including NAAG-hydrolyzing activity, inhibitor binding, and homodimerization. This is likely due to the fact that T269S is the only variant from our series in which the substituting amino acid can still engage Ca 2+ . This assumption is corroborated by the properties of the T269V and T269A mutants. Neither of these substitutions can coordinate Ca 2+ , and the resulting proteins are monomeric and catalytically incompetent. The impaired stability and hydrolytic activity of T269S can thus be attributed to the missing methyl group in the S269 side chain. In wtGCPII, the methyl group fills a cavity delineated by residues L268-R280, which form a loop that is intimately involved in dimerization contacts with the second GCPII monomer. The loop forms a concave, mostly hydrophobic patch that engages the complementary nonpolar face of the α20 helix formed by amino acids F737, V734, Y733, and R730 of the second monomer (Supporting Information Figure S2A ). Additionally, the side chain of Glu276, positioned at the side of the loop, interacts with the N-linked carbohydrate chain (hydrogen bonds between the hydroxyl groups of α-and β-mannoses and the γ-carboxylate of Glu276) at dark gray shows conserved amino acids, while light gray indicates similar residues (scoring >0.5 in the Gonnet PAM 250 matrix). SGAP was aligned to the GCPII protease domain only because it is lacks the other two domains. B, Structural alignment of two secondary structural regions-the loop and the α9 helix-where amino acids coordinating Ca 2+ (spheres) are positioned is shown.
The color code corresponds to panel C, where GCPII is colored cyan. C, Structural alignment of all four GCPII homologs (PDB codes: GCPII: 3D7H, GCPIII: 3FF3, NAALADaseL: 4TWE, TfR: 1DE4, and SGAP: 1CP7). The quantification of sequence homology (similarity and identity) was based on ClustalX2 sequence alignment using groups of similar residues (GAVLI, FYW, CM, ST, KRH, DENQ, P). Structures were aligned in PyMol software by Cα atoms, and RMSDs were calculated for these atoms.
Asn638 of the second GCPII monomer (Supporting Information Figure S2B ). This glycosylation is indispensable for GCPII activity and is predicted to be implicated in GCPII dimerization. 33 Clearly, the stability and proper conformation of the loop is important for homodimerization and preservation of the three-dimensional fold of the enzyme. Even a slight destabilization can disrupt the homodimerization interface, leading to destabilization of the overall fold of GCPII. Despite extensive efforts, we were unable to obtain diffracting crystals of any of the GCPII mutants, most likely due to the inherent instability of monomeric GCPII variants. However, combined results from our multifaceted biophysical and enzymatic approach offer a clear picture of the importance of Ca 2+ for GCPII stability and enzymatic activity.
Mechanistically, we propose that disruption of the Ca 2+ coordination sphere results in local unfolding of the L268-R280 loop at the monomer-monomer boundary. This in turn leads to destabilization of the physiologic GCPII homodimer assembly, exposing the extensive 2457 Å 2 dimeric interface that precipitates the collapse of the three-dimensional structure of the enzyme with the concomitant loss of its enzymatic activity. It remains to be seen whether the role of the calcium ion in the physiological context extends beyond its critical contribution to the proper folding of the nascent GCPII peptide and stabilizing its threedimensional structure. At present, no natural polymorphism in the GCPII gene has been ascribed for any amino acids studied in this work, though such polymorphism would likely led to the expression of the non-functional protein. Similarly, NAAG hydrolysis by GCPII is not regulated by the concentration of calcium ions in the assay buffer in vitro (data not shown). However, given the different enzymatic as well as non-enzymatic roles of GCPII in physiology, the notion of modulation of GCPII function by calcium ions in vivo warrant further studies.
Materials and Methods
Site-directed mutagenesis
Plasmids encoding GCPII mutants were generated by the standard QuikChange site-directed mutagenesis approach using sets of matching mutagenesis primers (listed in Supporting Information Table S1 ) with the pMT/BiP/SLIN/GCPII vector as a template. 34 This vector includes the extracellular part of GCPII (residues 44-750) cloned in frame with the BiP secretion signal and the N-terminal SLIN tag (Supporting Information Figure S1 ) to facilitate secretion into the growth media and affinity purification, respectively. The identity of all clones was verified by Sanger DNA sequencing.
Expression and purification
GCPII variants were expressed and purified using protocols reported previously for the wild-type protein. 34 Briefly, plasmids encoding GCPII variants were cotransfected into Schneider's Drosophila S2 cells (Invitrogen, CA) using Effectene transfection reagent (Qiagen) together with the pCoBlast selection plasmid (Invitrogen, CA) in a 20:1 ratio. Stable transfectants were selected in SFX media supplemented with 10% fetal bovine serum and blasticidin (30 μg/ mL, Invivogen, CA). Individual GCPII variants were expressed into the culture medium. The medium was concentrated by tangential flow filtration (TFF, Millipore, Molsheim, France), dialyzed against buffer suitable for subsequent purification (50 mM Tris-HCl, 150 mM NaCl, pH 8.0) and purified by StrepTactin affinity chromatography (Strep-Tactin Superflow, IBA, Germany) and SEC on an ENrich 650 10 × 300 column (BioRad, CA) in TBS buffer (50 mM TrisHCl, 150 mM NaCl, pH 7.4).
Analytical SEC
Analytical SEC was used to estimate the approximate size of monodisperse fractions of GCPII mutants in solution using a Shodex OHpak SB-804 HQ analytical column (8 × 300 mm) mounted to a Shimadzu Prominence HPLC system (Shimadzu, Japan) with TBS as a mobile phase. A 10 μL aliquot of GCPII variant (0.5 mg/mL) was injected onto the column, and protein elution was monitored by the absorbance of aromatic residues at λ = 280 nm. The molecular weights of GCPII variants were estimated based on a calibration curve of protein standards.
Activity assay
The enzymatic activity of GCPII variants was determined using 3 H-labeled N-acetyl-aspartyl-glutamate ( 3 H-NAAG) as a substrate as described elsewhere. 34 Briefly, individual mutants (at several concentrations) were preincubated in TBS for 15 min at 37 C in a total volume of 80 μL. The reaction was initiated by addition of 40 μL of a mixture of 0.31 μM NAAG and 15 nM 3 H-NAAG (49.1 Ci/mmol in 20 mM Tris buffer, Perkin Elmer) to a total reaction volume of 120 μL. After 20 min, the reaction was terminated by addition of 120 μL of 200 mM potassium phosphate, 50 mM EDTA, 2 mM β-mercaptoethanol, pH 7.4. The released glutamate was separated from the reaction mixture by ion-exchange chromatography and quantified by liquid scintillation. The relative activities of individual GCPII mutants were then calculated from the amount of hydrolyzed NAAG relative to the amount of GCPII added to the reaction and scaled to the activity of the wild-type enzyme (100%). Kinetic parameters (K M and k cat values) were determined for wtGCPII and the T269S variant, using NAAG concentrations ranging from 0.1 to 25 μM. Duplicate reactions were carried out for each data point. The kinetic parameters were calculated using GraphPad Prism software (GraphPad Software, San Diego, CA).
FP assay
The ability of GCPII mutants to bind an active sitetargeting fluorescent probe was assessed using a previously described FP assay. 19 Briefly, the TMR-XLys-urea-Glu fluorescent probe (5 nM) was mixed with a GCPII variant (50 nM) in TBS in a total volume of 30 μL in 384-well plates. Following a 20-min incubation, the FP was measured using a CLARIOstar microplate reader (BMG labtech, Germany), according to the published protocol. 19 In some cases, a dilution series of a GCPII variant (from 0.1 to 500 nM) was incubated with 5 nM TMR-X-Lys-urea-Glu, and binding curves were determined from FP signals.
Differential scanning fluorimetry (DSF)
Melting curves of individual GCPII variants were measured using a Prometheus NT.48 label-free nanoDSF instrument (NanoTemper Technologies, Germany). The protein was diluted in TBS (0.1 mg/mL) and transferred to a standard measurement capillary. Melting curves were determined in the 15-95 C range with a temperature shift rate of 1 C/min. To assess GCPII stabilization by an active site-targeting compound, the inhibitor CTT54 was added to the protein solution to a final concentration of 50 μM, and the mixture was preincubated for 15 min prior to DSF measurement.
CD spectroscopy
CD spectra were measured for both aggregated and monodisperse forms of all GCPII variants. Proteins were diluted to a final concentration of 0.1 mg/mL in water to suppress the background signal caused by TBS in the low wavelength range (195-260 nm). Spectra were collected using a Chirascan Plus spectrometer (Applied Photophysics, UK).
